The Delhi High Court has officially declared GSK's CALPOL as a well-known trademark amid a trademark infringement suit. This recognition acknowledges the brand's reputation and protects it from unauthorized use.
Delhi High Court Recognizes CALPOL as Well-Known Trademark
In a significant ruling, the Delhi High Court has recognized GlaxoSmithKline Pharmaceuticals Limited’s (GSK) pain and fever medicine brand CALPOL as a well-known trademark. This declaration was made during a trademark infringement suit against Walter Healthcare Private Limited, which was found to be using a similar mark, WALPOL.
Justice Jyoti Singh noted that CALPOL met the criteria set forth under the Trade Marks Act, 1999, to be recognized as a well-known mark, thus affording it heightened protection against unauthorized use. The decision underscores the brand's established reputation and ensures that its identity remains safeguarded in the marketplace.
This ruling is particularly important for trademark practitioners, as it sets a precedent for evaluating what constitutes a well-known trademark. Legal professionals must stay informed about this evolving landscape as it impacts trademark registration and enforcement strategies moving forward.
Citations
- GSK Vs Walter Healthcare (2026)
